Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01424176 · ClinicalTrials.gov registry record · Phase 1
Dexpramipexole Renal PK Study
A Phase 1 study, sponsored by Knopp Biosciences.
- Completed
- Registry status
- Phase 1
- Development phase
- 36
- Enrollment target
NCT01424176 is a Phase 1 study that has completed, run by Knopp Biosciences. The registered enrollment target is 36 participants.
The verdict
NCT01424176, a Phase 1 study, has completed, sponsored by Knopp Biosciences.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 36 participants
- Enrollment target
Study Summary
This is a multicenter, open-label, single-dose, PK and safety study in subjects with various stages of renal impairment.
Interventions
- DRUG Dexpramipexole (dose 1)
- DRUG Dexpramipexole (dose 2)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2011-07 |
| Est. Completion | 2012-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01424176
The ClinicalTrials.gov registry entry for NCT01424176 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Knopp Biosciences, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dexpramipexole (dose 1) is the first listed.
NCT01424176 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01424176 about?
NCT01424176 is a clinical study titled "Dexpramipexole Renal PK Study". This is a multicenter, open-label, single-dose, PK and safety study in subjects with various stages of renal impairment.
What is the current status of trial NCT01424176?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2011-07. Estimated completion is 2012-01.
What interventions are being tested in trial NCT01424176?
The interventions under investigation include: Dexpramipexole (dose 1) (DRUG), Dexpramipexole (dose 2) (DRUG).
Who is sponsoring clinical trial NCT01424176?
This trial is sponsored by Knopp Biosciences, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.